Predicting Risk Versus Predicting Potential Survival Benefit Using 123I- m IBG Imaging in Patients with Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data from the Prospective ADMIRE-HF Study

Circulation: Cardiovascular Imaging

Volumn 8, Issue 12, 2015, Pages

  Hachamovitch, Rory ^a   Nutter, Benjamin ^a   Menon, Venu ^a   Cerqueira, Manuel D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

defibrillators; heart failure; prognosis; radioisotopes; survival

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BRAIN NATRIURETIC PEPTIDE; CREATININE; TETROFOSMIN TC 99M; (3 IODOBENZYL)GUANIDINE; RADIOPHARMACEUTICAL AGENT;

ADREVIEW MYOCARDIAL IMAGING FOR RISK EVALUATION IN HEART FAILURE; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ASSESSMENT OF HUMANS; CAUSE OF DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLIC DYSFUNCTION; ADVERSE EFFECTS; CARDIOVERSION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; DEVICES; DISEASE FREE SURVIVAL; EUROPE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NONLINEAR SYSTEM; NORTH AMERICA; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SCINTISCANNING; STATISTICAL MODEL; SYSTOLE; TIME FACTOR; TREATMENT OUTCOME;

3-IODOBENZYLGUANIDINE; AGED; CHI-SQUARE DISTRIBUTION; DECISION SUPPORT TECHNIQUES; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; EUROPE; FEMALE; HEART FAILURE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONLINEAR DYNAMICS; NORTH AMERICA; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; SYSTOLE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84951114979     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.114.003110     Document Type: Article

References (31)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220. doi: 10.1161/CIR.0b013e31823ac046.
2. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med. 2007;147:251-262.
3. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295:809-818. doi: 10.1001/jama.295.7.809.
4. Liu SS, Monti J, Kargbo HM, Athar MW, Parakh K. Frontiers of therapy for patients with heart failure. Am J Med. 2013;126:6-12.e6. doi: 10.1016/j.amjmed.2012.04.033.
5. Scott PA, Morgan JM, Carroll N, Murday DC, Roberts PR, Peebles CR, Harden SP, Curzen NP. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol. 2011;4:324-330. doi: 10.1161/CIRCEP.110.959544.
6. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Randé JL, Duval AM, Loisance D, Castaigne A, Syrota A. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med. 1999;40:917-923.
7. Simöes MV, Barthel P, Matsunari I, Nekolla SG, Schömig A, Schwaiger M, Schmidt G, Bengel FM. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J. 2004;25:551-557. doi: 10.1016/j.ehj.2004.02.016.
8. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55:2769-2777. doi: 10.1016/j.jacc.2009.12.066.
9. Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3:92-100. doi: 10.1016/j.jcmg.2009.07.014.
10. Gerson MC, Abdallah M, Muth JN, Costea AI. Will imaging assist in the selection of patients with heart failure for an ICD? JACC Cardiovasc Imaging. 2010;3:101-110. doi: 10.1016/j.jcmg.2009.07.013.
11. Jacobson AF, Lombard J, Banerjee G, Camici PG. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials. J Nucl Cardiol. 2009;16:113-121. doi: 10.1007/s12350-008-9008-2.
12. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J; ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212-2221. doi: 10.1016/j.jacc.2010.01.014.
13. Nagahara D, Nakata T, Hashimoto A, Wakabayashi T, Kyuma M, Noda R, Shimoshige S, Uno K, Tsuchihashi K, Shimamoto K. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function. J Nucl Med. 2008;49:225-233. doi: 10.2967/jnumed.107.042564.
14. Nishisato K, Hashimoto A, Nakata T, Doi T, Yamamoto H, Nagahara D, Shimoshige S, Yuda S, Tsuchihashi K, Shimamoto K. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs. J Nucl Med. 2010;51:1241-1249. doi: 10.2967/jnumed.110.074971.
15. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147-1159. doi: 10.1093/eurheartj/ehn113.
16. Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL Jr, Hutson AD, Dekemp RA, Haka MS, Sajjad M, Cimato TR, Curtis AB, Cain ME, Canty JM Jr. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63:141-149. doi: 10.1016/j. jacc.2013.07.096.
17. Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, Unlu M, Estorch M, Banerjee G, Jacobson AF. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging. 2008;35:535-546. doi: 10.1007/s00259-007-0639-3.
18. Jacobson A, Lessig HJ, Gerson MC, Cerqueira MD, Narula J. 123I-mIBG myocardial scintigraphy as an indicator of likelihood of heart failure hospitalization in heart failure patients: additional observations from ADMIRE-. Eur Heart J Suppl. 2011;13:A55.
19. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
20. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34:618-620.
21. Cai T, Cheng SC, Wei LJ. Semiparametric mixed-effects models for clustered failure time data. J Am Stat Assoc. 2002;97:514-522.
22. Ripatti S, Palmgren J. Estimation of multivariate frailty models using penalized partial likelihood. Biometrics. 2000;56:1016-1022.
23. R Development Core Team. \R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2012.
24. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900-2907. doi: 10.1161/01.CIR.0000072790.23090.41.
25. Hachamovitch R, Kang X, Amanullah AM, Abidov A, Hayes SW, Friedman JD, Cohen I, Thomson LE, Germano G, Berman DS. Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly. Circulation. 2009;120:2197-2206. doi: 10.1161/CIRCULATIONAHA.108.817387.
26. Hachamovitch R, Rozanski A, Hayes SW, Thomson LE, Germano G, Friedman JD, Cohen I, Berman DS. Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol. 2006;13:768-778. doi: 10.1016/j. nuclcard.2006.08.017.
27. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, Hayes SW, Cohen I, Germano G, Berman DS. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011;32:1012-1024. doi: 10.1093/eurheartj/ehq500.
28. Hachamovitch R, Di Carli MF. Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation. 2008;117:2793-2801. doi: 10.1161/CIRCULATIONAHA.107.714006.
29. Smith Sehdev AE, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med. 2001;161:277-284.
30. Sington JD, Cottrell BJ. Analysis of the sensitivity of death certificates in 440 hospital deaths: a comparison with necropsy findings. J Clin Pathol. 2002;55:499-502.
31. Hoyert DL. The Changing Profile of Autopsied Deaths in the United States, 1972-2007. Hyattsville, MD: National Center for Health Statistics, 2011.